Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulatory treatment of recurrent cystitis
DRKS00025964Phase 2Active, not recruiting
- Sponsor
- SelectImmune Pharma AB (Lund, Schweden)Org nr: 559104-6874 Prof. Dr. med. Catharina Svanborg BMC D10, Klinikgatan 32
- Start
- Jul 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Lower Urinary Tract Infection (LUTI) and cystitis comparing Kineret with Nitrofurantoin (2 arms). Started Jul 2021; status: active, not recruiting.
02
Drugs
anakinranitrofurantoin
03
Conditions
Lower Urinary Tract Infection (LUTI)cystitis
Beyond the preview
Go deeper on DRKS00025964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00025964.